Cytarabine can be used along with other cytostatics to treat diseases such as leukemia and lymphoma, and belongs to an antineoplastic class of drugs. However, there are some side effects as well as contraindications that need to be understood.
In the treatment of acute myeloid leukemia, cytarabine is often used alone or in combination with other chemotherapeutic agents as the standard chemotherapy regimen. Cytarabine is also commonly used in the treatment of acute lymphoblastic leukemia. In addition, cytarabine alone or in combination with methotrexate is used in central nervous system leukemias and lymphomas.
Cytarabine is a myelosuppressant, which may cause myelosuppression, skin and mucous membrane damage, infections, musculoskeletal abnormalities, and connective tissue abnormalities, and even sepsis, pneumonia, cellulitis at the site of the injection, etc., so it is important to follow your doctor’s instructions strictly.
It should not be used by those who are allergic to the active ingredients of this product. Those who have used other drugs induced myelosuppression, generally do not receive cytarabine treatment. Toxic Encephalopathy, Degenerative Encephalopathy.
Cytarabine is an anti-tumor drug, and the drug should be used in strict accordance with the doctor’s instructions so as not to affect the condition.